Fundraising FoxPfizer Venture Investments — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
BioAtla develops novel monoclonal antibody and cell-based therapeutics for cancer treatment using proprietary platforms including Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!).
BiotechHealthtechMedical DevicesSan Diego, US
Jay M. Short(Executive Officer, Director)Richard A. Waldron(Executive Officer)inCarolyn Short(Director)
Co-investorsKeshif VenturesPappas CapitalHBM Healthcare InvestmentsPappas CapitalPfizer VenturesSoleus Capital
BiotechSanta Clara, US
Jeffrey Glenn(Director)David Cory(Executive Officer, Director)
BoardNina Kjellson(Director)inEd Engleman(Director)
Co-investorsCanaan PartnersVivo CapitalVivo Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.